Login

Samsung Biologics to acquire facility outside DC for first US manufacturing plant

South Korean manufacturer agrees to pay $280 million for two-building complex in Rockville, Maryland
Samsung Biologics' deal would give it control of the Human Genome Sciences campus near Shady Grove Hospital. (CoStar)
Samsung Biologics' deal would give it control of the Human Genome Sciences campus near Shady Grove Hospital. (CoStar)
CoStar News
December 22, 2025 | 7:49 P.M.

A biotech division of South Korean conglomerate Samsung is set to establish its first U.S.-based manufacturing hub with the acquisition of a two-building complex in suburban Washington, D.C.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE